The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
April 7, 2024
Stories this photo appears in:
April 7, 2024 2:50 p.m.
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.